Ceftaroline fosamil: Difference between revisions
| Line 5: | Line 5: | ||
==Adult Dosing== | ==Adult Dosing== | ||
===[[Pneumonia (Main)|Community Acquired Pneumonia]]=== | |||
*600 mg IV q12h x5-7 days | |||
===[[Cellulitis]]=== | |||
*600 mg IV q12h x5-14 days | |||
===Renal Dosing=== | |||
*CrCl 30-50: 400 mg q12h; CrCl 15-30: 300 mg q12h; ESRD/HD: 200 mg q12h | |||
===Hepatic Dosing=== | |||
*No adjustment | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revision as of 01:56, 17 May 2014
General
- Type: 5th Generation Cephalosporin
- Dosage Forms: IV
- Common Trade Names: Teflro
Adult Dosing
Community Acquired Pneumonia
- 600 mg IV q12h x5-7 days
Cellulitis
- 600 mg IV q12h x5-14 days
Renal Dosing
- CrCl 30-50: 400 mg q12h; CrCl 15-30: 300 mg q12h; ESRD/HD: 200 mg q12h
Hepatic Dosing
- No adjustment
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: